Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-04

Clinical Trial Update: Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fixed-dose combination of nebivolol and valsartan for stage 1–2 hypertension has completed. The update notes completion but does not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension | Phase 3 | Status: COMPLETED